previous compound ID: 2640 next compound
InChIKey: XUBOMFCQGDBHNK-UHFFFAOYSA-N
SMILES: CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "GW Carlile" "D Rotin" "J Goepp" "SD Macknight" "B Kus" "R Robert" "E Matthes" "DY Thomas" "J Liao"

chemical graph of compound 2640





CID is 5379
synonyms found at PubChem are:
Gatifloxacin, 112811-59-3, Tequin, Zymar, Gatiflo, Gatifloxacine, Gatiquin, Gatispan, Gatilox, Zymaxid, Gaity, AM-1155, AM 1155, gatifloxin, CG 5501, Gatifloxacin [USAN:INN], gatifloxacino, gatifloxacinum, BMS-206584, Bonoq, 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, BMS 206584-01, PD 135432, Gatifloxacin (TN), Gatifloxacin (INN), GTFX, gatifloxacin anhydrous, Zymer (TN), CHEMBL31, Gatifloxacin hydrate, 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-, Tequin in dextrose 5% in plastic container, CHEBI:5280, AM-1155 (*Sesquihydrate*), Gatifloxacin & Gamma Interferon, 160738-57-8, (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, CG-5501, NCGC00068236-02, CPD000043336, PD135432, BMS-206584-01, PD-135432, Gatiflo (TN), Tequin (TN), G-2380, Zymar (TN), DSSTox_CID_25704, DSSTox_RID_81076, DSSTox_GSID_45704, Tymer, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid, 1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid, 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, SMR000043336, CAS-112811-59-3, 1-cyclopropyl-6-fluoro-8-methoxy-7-, SR-01000610458, (3-methylpiperazin-1-yl)-4-oxo-1,4-, Gatifloxcin, Zymer, Tequin and Zymar, Gatifloxacin,(S), Kinome_3137, PubChem21048, Spectrum_001909, Gatiflo,Tequin and Zymar, 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid sesquihydrate, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-piperazin-1-yl)- 4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, Spectrum2_000487, Spectrum3_000999, Spectrum4_001127, Spectrum5_001468, D03CQE, SCHEMBL22591, BSPBio_002697, KBioGR_001613, KBioSS_002448, MLS000040259, MLS000759493, MLS006011836, SPECTRUM1504272, SPBio_000353, Gatifloxacin Sesquihydrate,(S), AC1L1K82, DTXSID5045704, CTK6J4376, KBio2_002442, KBio2_005010, KBio2_007578, KBio3_001917, KS-00000IXR, MolPort-001-738-626, XUBOMFCQGDBHNK-UHFFFAOYSA-N, HMS1922J15, HMS2090K10, HMS2093G06, HMS2233D20, HMS3259P06, HMS3372J10, HMS3372J12, HMS3715N03, Pharmakon1600-01504272, ALBB-028535, BCP13408, RKL10068, ZX-AN079351, ZX-AP010622, Tox21_110984, BBL010485, BDBM50117914, BG0576, CCG-39529, CG5501, NSC758701, s1340, STK801620, AKOS004119932, AKOS016340697, Tox21_110984_1, AC-1944, API0002807, CS-1841, DB01044, Gatiflo,Tequin and Zymar, Gatifloxacin, KS-1066, MCULE-4557972261, NC00702, NSC-758701, RTR-002479, VA11838, NCGC00068236-03, NCGC00068236-04, NCGC00068236-05, NCGC00068236-06, NCGC00068236-07, NCGC00068236-08, NCGC00095126-01, NCGC00095126-02, NCGC00178525-01, AN-14480, AN-30562, AN-31062, BC204030, CC-34682, HY-10581, KB-71352, SAM001246715, SAM002589955, SC-12171, SBI-0206764.P001, AB0012064, AB1009302, AB2000056, AX8018671, DB-019145, LS-184402, TL8001438, TR-002479, FT-0082686, FT-0626635, FT-0631189, G0325, C07661, D08011, AB00171654-13, AB00171654-14, AB00171654_16, AB00171654_17, 811G593, A802657, C-21242, Gatifloxacin, Antibiotic for Culture Media Use Only, SR-01000610458-2, SR-01000610458-3, BRD-A74980173-001-02-8, BRD-A74980173-001-06-9, 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-, 1-Cyclopropyl-6-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid, 1-Cyclopropyl-6-6-fluoro-1,4-dihydro-8-methoxy-7-(3methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoranyl-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxidanylidene-quinoline-3-carboxylic acid, 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazino)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid, 1-cyclopropyl-7-(3-methyl-1-piperazinyl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-, AC1NJHTG, MolPort-000-776-959, STL048947, AKOS005702286, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-4-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-4-ium-1-yl)-4-oxoquinoline-3-carboxylate